FDA Approves First New Sunscreen Ingredient in 25 Years

Your sunscreen is about to get a major upgrade thanks to a long-awaited FDA decision that just closed a decades-long gap in American sun protection.

The Food and Drug Administration approved bemotrizinol, marking the first new sunscreen ingredient added to the approved list since 1999. That's right: American sunscreen technology has been frozen in time for over 25 years while the rest of the world moved ahead.

Bemotrizinol has been protecting skin across Europe and Asia since 1999, sold under brand names like Parsol Shield and Tinosorb. The ingredient works by absorbing harmful ultraviolet rays before they can damage your skin.

The Environmental Working Group called the approval a "landmark decision for public health and consumer protection." David Andrews, the organization's chief science officer, celebrated what he called closing "the UVA protection gap in U.S. sunscreens."

The approval gives European skincare company DSM-Firmenich exclusive rights to market their Parsol Shield formula in the United States for the next 18 months. After that window closes, other manufacturers can start incorporating the ingredient into their products too.

The Ripple Effect

This single approval could transform how millions of Americans protect themselves from sun damage and skin cancer. Better sunscreen ingredients mean stronger defense against both UVA and UVB rays, the culprits behind premature aging and melanoma.

The decision also signals that the FDA is finally catching up with international standards after years of advocacy from health groups and frustrated consumers. Americans have watched friends abroad enjoy superior sun protection while stuck with outdated formulas at home.

For beachgoers, outdoor workers, parents slathering kids before summer camp, and anyone who spends time outside, this means real progress toward safer, more effective protection that's been proven safe for decades overseas.

Better sunscreen is finally coming to America, and your skin will thank you.